News
19h
Fintel on MSNCantor Fitzgerald Initiates Coverage of Vaxcyte (PCVX) with Overweight RecommendationFintel reports that on April 22, 2025, Cantor Fitzgerald initiated coverage of Vaxcyte (NasdaqGS:PCVX) with a Overweight ...
5d
Barchart on MSN2 ‘Strong Buy’ Growth Stocks That Could Gain More Than 340%In a volatile market, growth stocks may seem like the least attractive options. That is because growth stocks are shares of ...
16h
Medpage Today on MSNRotavirus Vaccines Involve Several Special ConsiderationsThere are two vaccines approved by the FDA -- RotaTeq and Rotarix -- that protect against rotavirus, the most common cause of ...
Vaccinations are key amid recent measles outbreaks in the U.S., including Michigan. Here's a look at what to know.
Over the past years, China has achieved notable breakthroughs in vaccine technology. Milestones include the successful development of homegrown HPV and Ebola vaccines, as well as advances in ...
Pneumococcal conjugate vaccines, including more than seven serotypes, will have potential for a larger effect than PCV7 in many countries, including Norway. A 13-valent pneumococcal conjugate ...
3don MSN
The findings from Fred Hutch Cancer Center suggest next step of exploring whether one dose of the vaccine is enough.
The ACIP voted that Penmenvy may be used as part of the adolescent meningococcal vaccination schedule as an alternative to separate administration of MenACWY and MenB. The Centers for Disease ...
replaced the oral polio vaccine. Then, in 2000, the pneumococcal conjugate vaccine (PCV) was added and hepatitis A was recommended to children in high-risk areas. Table 1 provides information ...
The pneumococcal conjugate vaccine – codenamed PCV21/GBP410 – has started pivotal trials in the prevention of both paediatric Streptococcus pneumoniae, which remains a major public health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results